Package 68210-4096-1

Brand: naproxen sodium

Generic: naproxen sodium
NDC Package

Package Facts

Identity

Package NDC 68210-4096-1
Digits Only 6821040961
Product NDC 68210-4096
Product ID 68210-4096_2a8235d0-4618-0572-e063-6394a90a0d1a
Description

365 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-4096-1)

Marketing

Marketing Status
Marketed Since 2020-07-02
Brand naproxen sodium
Generic naproxen sodium
Sample Package No

Linked Drug Pages (1)

NAPROXEN SODIUM ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2a8235d0-4618-0572-e063-6394a90a0d1a", "openfda": {"unii": ["9TN87S3A3C"], "spl_set_id": ["a690dc39-95f2-4853-a291-05d7dc9a1551"], "manufacturer_name": ["SPIRIT PHARMACEUTICALS,LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "365 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68210-4096-1)", "package_ndc": "68210-4096-1", "marketing_start_date": "20200702"}], "brand_name": "NAPROXEN SODIUM", "product_id": "68210-4096_2a8235d0-4618-0572-e063-6394a90a0d1a", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "68210-4096", "generic_name": "NAPROXEN SODIUM", "labeler_name": "SPIRIT PHARMACEUTICALS,LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "NAPROXEN SODIUM", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA091353", "marketing_category": "ANDA", "marketing_start_date": "20200702", "listing_expiration_date": "20261231"}